The initial interaction between virus and host occurs via molecular interactions of viral attachment proteins and receptors on host cells. Therefore, receptor recognition is a critical host cell determinant and may play a key regulatory role in viral pathogenesis. The polyomavirus JC virus (JCV) is a ubiquitous human pathogen (21, 25, 32) that is initially subclinical yet establishes a persistent infection in the kidney (11). In immunosuppressed individuals JCV can become reactivated, leading to infection in the central nervous system (CNS) (13) (14) (15) 20) , where the virus specifically targets glial cells, including astrocytes and the myelin-producing cells, oligodendrocytes (40, 48) . JCV infection and cytolytic destruction of oligodendroglia cause the fatal disease progressive multifocal leukoencephalopathy (PML) (1, 22). The most common cause of PML is associated with human immunodeficiency virus (HIV) and AIDS (10, 23). However, in recent years PML has been reported in patients receiving immunosuppressive therapies for autoimmune diseases such as Crohn's disease (44), multiple sclerosis (MS) (24, 26, 28, 47) , systemic lupus erythematosus (5, 33), and rheumatoid arthritis (5, 19, 37). The prognosis of PML is bleak, as the disease progresses rapidly and usually proves fatal within 1 year of the onset of symptoms. While current treatment options for PML are limited (23), recent studies suggest that mirtazapine, a serotonin receptor antagonist, may be capable of slowing the progression of PML (6, 27, 45, 46) . JCV has a nonenveloped, icosahedral capsid that encapsidates a circular double-stranded DNA (dsDNA) genome (39). JCV attachment to cells is mediated by an N-linked glycoprotein with either ␣(2,3)-or ␣(2,6)-linked sialic acid (16, 31), suggesting that N-linked glycosylation of cellular receptors is important for JCV infection. N-linked glycosylation is a posttranslational process by which oligosaccharides are added to asparagine residues, and this modification is important for protein processing, folding, expression, and function (43). Previous studies from our laboratory revealed that the JCV also requires the serotonin 5-hydroxytryptamine 2A receptor (5-HT 2A R) to mediate JCV infection (18, 35, 38) , while others report that JCV infection can occur in the absence of 5-HT 2A R (7, 8) . 5-HT 2A R is a seven-transmembrane-spanning G-protein-coupled receptor that belongs to a large family of 5-HT serotonin receptors. 5-HT 2A R is abundantly expressed on cells in the brain (4), including glial cells (3), and in the kidney (4), which parallels the sites of JCV infection. N-linked glycosylation plays a key regulatory role in the function of serotonin receptors. Mutation of N-linked glycosylation sites in human 5-HT 3A R and 5-HT 5A R results in decreased expression at the plasma membrane, which is critical for receptor function (17, 34) . N-linked glycosylation of murine 5-HT 3A R regulates plasma membrane targeting, ligand binding, Ca 2ϩ flux, and receptor trafficking (36), suggesting that glycosylation is essential for expression and function of serotonin receptors.
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While previous studies have concluded that JCV utilizes an N-linked glycoprotein with ␣(2,3)-linked sialic acid (31) or ␣(2,6)-linked sialic acid (16) and 5-HT 2A R (18) to initiate infection in host cells, the mechanism(s) by which JCV engages its cellular receptors and the importance of receptor glycosylation remain unclear. 5-HT 2A R contains potential asparagine Treatment of cells with tunicamycin. At 4 h posttransfection, cells were treated with 0.2 g/ml of tunicamycin (Sigma) (2) or an equivalent volume of methanol (MeOH) (vehicle control) in complete DMEM. Cells were incubated at 37°C for 24 h in the presence of tunicamycin. Cells were then infected as described below, treated with MeOH to fix cells for confocal microscopy, or harvested by mechanical scraping in phosphate-buffered saline (PBS) for immunoblot analysis.
Treatment of cells with neuraminidase. At 24 h posttransfection, cells were treated with 0.8 U/ml of neuraminidase from Vibrio cholerae (Sigma Aldrich, St. Louis, MO) in PBS (pH 6.5) with 1 mM MgCl 2 and 1 mM CaCl 2 at 37°C for 1 h. Cells were then washed twice with minimal essential medium (MEM) containing 2% FCS prior to infection.
Treatment of cells with PNGase F. At 24 h posttransfection, cells were treated with 2 or 10 U/l of glycerol free PNGase F (N-glycosidase F) (New England BioLabs, Ipswich, MA) in Hanks buffered salt solution (HBSS) (Invitrogen) at 37°C for 1 h (41). Cells were washed with MEM containing 2% FCS prior to infection.
Indirect immunofluorescence assay of JCV infection. Cells were infected with JCV at a multiplicity of infection (MOI) of 1 focus-forming unit (FFU)/cell in MEM containing 2% FCS at 37°C for 1 h, DMEM containing 5% FCS and penicillin-streptomycin was added, and cells were incubated at 37°C. At 48 h postinfection, cells were washed with PBS and fixed either in 2% paraformaldehyde (PFA) at room temperature (RT) for 10 min or in MeOH at Ϫ20°C for Ͼ10 min. Cells were washed with PBS, permeabilized with 0.5% Triton X-100 at RT for 15 min, and then blocked with 10% goat serum (MP Biomedicals, Solon, OH) in PBS at RT for 1 h. Cells were stained with the JCV T-Ag-specific antibody PAB962 (1:10) in PBS at 37°C for 1 h, washed with PBS, and then incubated with a goat anti-mouse Alexa 594 antibody (1:500) in PBS (Invitrogen) and washed with PBS. Coverslips were mounted on slides using Vectashield with DAPI (4Ј,6Ј-diamidino-2-phenylindole) (Vector Labs, Burlingame, CA). Cells were analyzed by epifluorescence microscopy (Nikon), and infected cells were quantitated based on nuclear T-Ag expression.
Confocal imaging of cell surface expression of 5-HT 2A R-YFP. Cells were washed with PBS at 24 h following transfection or tunicamycin treatment and fixed in cold MeOH at Ϫ20°C for Ͼ10 min. Cells were then washed, permeabilized using 1% Triton X-100 at RT for 5 min, and blocked in PBS with 5% bovine serum albumin (BSA) and 0.1% Tween 20 (PBS-BT) at RT for 30 min. Cells were stained with a plasma membrane marker (pan-cadherin-specific antibody; Abcam) (4 g/ml) in PBS-BT at RT for 1 h, washed in PBS-BT, incubated with a goat anti-rabbit Alexa 546 (Invitrogen) (1:1,000) in PBS-BT at RT for 1 h, and washed in PBS-BT. Coverslips were rinsed with distilled water prior to being mounted on slides using Vectashield with DAPI (Vector Labs). Cells were analyzed using a Zeiss 510 confocal microscope equipped with a Meta detector and Meta software (Carl Zeiss, New York, NY). Multiple images were captured using a 63ϫ objective. The cell surface expression of 5-HT 2A R-YFP was quantitated using Metamorph imaging software (Universal Imaging, Downingtown, PA). Images were separated by color and set to an inclusive threshold. A total of 35 individual cells per sample were outlined for measurement. Colocalization of 5-HT 2A R-YFP was quantitated as a function of pan-cadherin (a plasma membrane marker) to determine the percentage of 5-HT 2A R-YFP expressed on the cell surface.
Immunoblot analysis of 5-HT 2A R glycosylation. HEK293A cells were transfected as described above, washed with PBS, and harvested by mechanically scraping cells in PBS. Cells were pelleted and resuspended in 50 l of cold 50 mM Tris (pH 7.6) with protease inhibitor cocktail (PIC) (Sigma) on ice. Samples were sonicated using a 150 series Sonic Dismembrator (Fisher Scientific, Pittsburgh, PA) on a low-power setting equivalent to approximately 10 W on ice for 10 s and then pelleted at 19,060 ϫ g at 4°C for 10 min. Supernatants were removed, and pellets (membrane fraction) were resuspended in cold Tris buffer with PIC on ice and pelleted again. Pellets were resuspended in 50 l cold Tris buffer without PIC and mixed with 50 l of sample buffer (Bio-Rad, Hercules, CA). Samples were boiled at 95°C for 5 min, and 50 l of the sample was resolved by SDS-PAGE on 10% Tris-HCl gels (Bio-Rad). Proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Bio-Rad) using a semidry Trans Blot apparatus (Bio-Rad). Membranes were blocked in 5% milk-PBS-T overnight and then incubated with ab290 (1:2,000) in 5% milk-PBS-T at RT for 1 h and washed with PBS-T. Membranes were incubated with goat anti-rabbit Alexa 680 (Invitrogen) (1:2,000) in 5% milk-PBS-T at RT for 1 h and washed in PBS-T. Membranes were rinsed in PBS and analyzed using the LiCor Odyssey (LiCor Biosciences, Lincoln, NE). Images are shown in gray scale.
Statistical analysis. A two-tailed Student t test was performed using Microsoft Excel. P values of Ͻ0.05 were considered to be statistically significant. (Fig. 1) , we analyzed the nucleotide sequence of 5-HT 2A R for the presence of potential N-linked glycosylation sites. A potential N-linked glycosylation site is denoted by the motif Asn-X-Ser/Thr, where X is any amino acid. Upon sequence analysis of 5-HT 2A R, we observed eight potential Nlinked glycosylation sites at residues N8, N38, N44, N51, N54, N75, N107, and N384 ( Fig. 2A) . However, topographical analysis of the seven-transmembrane receptor revealed that N75 is localized at the plasma membrane and that sites N107 and N384 are expressed on intracellular loops, suggesting that these residues (Fig. 2B) . Mutation of individual N-linked glycosylation sites in 5-HT 2A R-YFP did not affect the capacity of 5-HT 2A R-YFP to support JCV infection. These data suggest that JC virus does not utilize a specific N-linked glycosylation site to mediate infection in a 5-HT 2A R-dependent manner. However, it was necessary to determine whether the cell surface expression of the serotonin receptor was affected by mutation of the potential glycosylation sites, as previous studies have found that point mutation of N-linked glycosylation sites in serotonin receptors interfered with cell surface expression and receptor functions (17, 34) . To test whether mutation of potential N-linked glycosylation sites affected the cell surface expression of 5-HT 2A R-YFP, HEK293A cells transfected with wild-type and mutant constructs were fixed at 24 h posttransfection, stained with the plasma membrane marker pan-cadherin, and analyzed by confocal microscopy (Fig.  3A) . 5-HT 2A R-YFP was observed at the cell surface as well as in other subcellular locations, and this likely represents receptor that is being processed or recycled. 5-HT 2A R-YFP cell surface expression was analyzed as a function of pan-cadherin expression using Metamorph imaging analysis to determine the percentage of 5-HT 2A R that was expressed at the cell surface (Fig. 3B) . Cell surface expression of the wild-type and mutant constructs was (Fig. 2B) . Thus, a 5-HT 2A R-YFP construct in which all five N-linked glycosylation sites were mutated to alanine residues (5-HT 2A R-YFP-N8/38/44/51/54A) was generated and tested for the capacity to support JCV infection (Fig. 4) . Mutation of (Fig. 5A) . 5-HT 2A R-YFP cell surface expression was analyzed as a function of pan-cadherin expression using Metamorph imaging analysis to determine the percentage of the receptor that was expressed at the plasma membrane (Fig. 5B) . Through imaging analysis it was determined that the cell surface expression of 5-HT 2A R-YFP-N8/38/44/51/54A is reduced, and the cellular expression pattern of 5-HT 2A R-YFP-N8/38/44/51/54A parallels that observed in tunicamycintreated 5-HT 2A R-YFP-expressing HEK293A cells (Fig. 5A  and B ). These data demonstrate that glycosylation of 5-HT 2A (Fig. 6B) . The apparent electrophoretic mobility of 5-HT 2A R-YFP was reduced by ϳ3 kDa by point mutations of individual N-linked glycosylation sites. However, mutation of all five sites resulted in a reduction in the ϳ75-kDa band as in the tunicamycintreated sample (Fig. 6B) , suggesting that inhibition of 5-HT 2A R N-linked glycosylation by either mutation or tunicamycin treatment results in an altered electrophoretic mobility profile. These data show that 5-HT 2A R is normally glycosylated and that glycosylation is critical for cell surface localization. (Fig. 1A) or mutation of all five N-linked glycosylation sites (Fig. 4) results in a decreased capacity of 5-HT 2A R to support JCV infection yet also reduces the cell surface expression of the receptor (Fig. 5) . Thus, to further address whether N-linked glycosylation of 5-HT 2A R is required for JCV infection, cells were treated with PNGase F to specifically remove N-linked oligosaccharides from the surface of 5-HT 2A R-YFP-expressing HEK293A cells (41) and then infected with JCV (Fig. 7A) . Interestingly, PNGase F had no effect on JCV infection. Immunoblot analysis revealed that PNGase F treatment of 5-HT 2A R-YFP-expressing cells resulted in an electrophoretic mobility pattern of 5-HT 2A R (Fig. 7B ) similar to that observed in tunicamycin-treated cells, suggesting that the PNGase F used in the experiments effectively removed cell surface Nlinked oligosaccharides. Taken together, these data indicate that the sialic acid component of the JCV receptor is not linked to 5-HT 2A R. reduced due to the decreased availability of the receptor. Moreover, the electrophoretic mobility of 5-HT 2A R was altered by tunicamycin treatment or mutation of all 5-HT 2A R N-linked glycosylation sites but was unaffected by mutation of individual N-linked glycosylation sites, suggesting that the receptor is normally glycosylated. PNGase F, which enzymatically removes N-linked oligosaccharides from the cell surface, does not affect JCV infection. Taken together, these data suggest that N-linked glycosylation of 5-HT 2A R is required for proper cell surface expression yet is not required for JCV infection. These findings provide a better understanding of how JC virus engages host cell receptors to mediate infection. This is also the first characterization of the glycosylation profile of the human 5-HT 2A R. Previous studies have suggested that glycosylation of serotonin receptors is essential for plasma membrane localization of the receptor, signaling events, and ligand binding (17, 34, 36) . For example, treatment of cells expressing human 5-HT 3A R with tunicamycin results in a reduction in the molecular weight of the receptor as assessed by electrophoretic mobility. Further, mutation of the individual N-linked glycosylation sites also results in a reduction in electrophoretic mobility of ϳ3 kDa, suggesting that human 5-HT 3A R is normally glycosylated by N-linked oligosaccharides. Mutation of these sites results in a decreased capacity for the receptor to support ligand binding, indicating an essential role for N-linked glycosylation in the function of human 5-HT 3A R (34). Thus, our data suggest that like for other serotonin receptor family members, N-linked glycosylation regulates the expression and function of the human 5-HT 2A receptor.
RESULTS

JCV infection of 5-HT
These data also show that N-linked glycosylation of 5-HT 2A R is important for receptor expression but not required for JCV infection. Point mutation of individual N-linked glycosylation sites in 5-HT 2A R did not affect the function of the receptor in JCV infection, indicating that JCV does not engage a specific N-linked sialic acid expressed on 5-HT 2A R. Treatment of 5-HT 2A R-expressing HEK293A cells with neuraminidase significantly reduced infection, indicating that the mechanism by which 5-HT 2A R mediates JCV infection is via sialic acid. These data further indicate that the sialic acid component is likely expressed on an alternate coreceptor.
JCV has a very restricted host cell tropism, infecting cells in the kidney (9, 12) , B lymphocytes of the bone marrow (9) , and oligodendrocytes and astrocytes in the CNS (40, 48) . Thus, it seems plausible that JCV could utilize sialic acid as a lowaffinity binding step to adhere to 5-HT 2A R, and then the virus may interact with specific residues in 5-HT 2A R to mediate entry into host cells. It is also possible that JCV engages sialic acid on another molecule through a low-affinity binding step and then interacts with 5-HT 2A R to mediate entry. A recent study reports that JCV isolates from PML patients contain polymorphisms in sialic acid binding domains in the viral capsid protein VP1 (42) , suggesting that the mechanism by which JCV engages host cell receptors in the brain may differ from that in the kidney or tissue culture systems. Given that JCV reactivation occurs during immunosuppression due to HIV/ AIDS or in patients receiving immunosuppressive therapies, it is possible that the virus engages host cell receptors in a different manner due to selective pressures in the host.
This study provides new information regarding the role of 5-HT 2A R in JCV infection and the development of PML. As treatment options for PML are very limited, the prognosis is dismal (23) . However, recent case studies have found that treatment of PML patients with mirtazapine (a serotonin 5-HT 2A , 5-HT 2C , and 5-HT 3 receptor antagonist used for treatment of depression) reduced the normally rapid progression of PML (6, 27, 45, 46) . Treatment of PML patients with mirtazapine was most effective when a patient was treated at the early onset of symptoms; therefore, this may provide a viable treatment option to extend the lives of PML patients (6) . These clinical studies suggest that treatment of PML patients with mirtazapine, a serotonin receptor antagonist, may effectively inhibit JCV binding to 5-HT 2A R on oligodendrocytes and thereby reduce JCV spread in the brain. This highlights the importance of understanding the molecular interactions between JCV and the 5-HT 2A receptor. Future studies will provide a platform for continued pharmacological development of 5-HT 2A receptor antagonists and inhibitors to treat and prevent PML.
